Clinical Trial: Safety and Metabolic Study of Highly Active Antiretroviral Therapy (HAART) in Malnourished Children With HIV
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: ART Pharmacokinetics, Mitochondrial Integrity, and Antioxidant Capacity in Severely Malnourished HIV-infected Malawian Children
Brief Summary: It is unclear whether children with HIV and severe acute malnutrition can be started on highly active antiretroviral therapy (HAART) safely while they are still malnourished and the manner in which this therapy should start. This study will examine the safety, efficacy, and metabolism of children started on HAART while still severely malnourished.
Detailed Summary:
Sponsor: Washington University School of Medicine
Current Primary Outcome: Pharmacokinetics [ Time Frame: 6 weeks ]
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Washington University School of Medicine
Dates:
Date Received: February 3, 2012
Date Started: July 2011
Date Completion:
Last Updated: January 22, 2014
Last Verified: January 2014